People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their odds for a dangerous blood clot, new research finds. The study found that folks with diabetes who were using the drugs lowered their odds for a form of clot called venous thromboembolism (VTE)…  read on >  read on >

It has happened to everyone during the holidays: Unable to resist the treats and feasts of the season, you overindulge and your gut revolts. Luckily, one expert has some solid guidance on how to navigate the culinary temptations that come with the festivities. Eating too much holiday fare can disrupt the digestive system, leading to…  read on >  read on >

Eating lots of ultra-processed foods appears linked to a buildup of fat in the thighs, which in turn raises a person’s odds for arthritis in the knees, new research shows. “In an adult population at risk for but without knee or hip osteoarthritis, consuming ultra-processed foods is linked to increased fat within the thigh muscles,”…  read on >  read on >

The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs’ cost should be covered by Medicare, Medicaid and private insurers. Late last month, the Biden administration proposed that the drugs be covered by Medicare and Medicaid, a move that would have to be approved by the…  read on >  read on >